Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis.
Gemma K ReynoldsMary Ann AndersonKarin ThurskyBenjamin W TehMonica A SlavinPublished in: Leukemia & lymphoma (2023)
T/Natural killer (NK) cell lymphomas (TCL) represent a heterogenous subgroup of non-Hodgkin lymphoma, associated with poorer prognosis and higher treatment toxicity. A cohesive synthesis of infection outcomes among TCL patients is lacking. International guidelines offer no specific recommendations regarding prophylaxis or supportive infection care for TCL patients. This systematic narrative review highlights infection outcomes in TCL patients treated with conventional, and novel therapies. Recommendations for infection screening, antimicrobial prophylaxis and vaccination strategies are outined.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- healthcare
- palliative care
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- staphylococcus aureus
- oxidative stress
- metabolic syndrome
- patient reported outcomes
- clinical trial
- chronic pain
- health insurance
- affordable care act
- placebo controlled